- The Centers for Disease Control and Prevention (CDC) has confirmed that an ongoing Ebola outbreak in remote regions of the Democratic Republic of the Congo (DRC) and Uganda has crossed 1,000 cases, officially making it the second-largest Ebola outbreak in history.
- The current surge is driven by the rare Bundibugyo orthoebolavirus strain, for which there is currently no approved medical vaccine, leaving healthcare workers to rely strictly on supportive treatment to manage a disease that historically carries up to a 55% mortality rate.
- In response to the rapid spread, which has reached Uganda’s capital city of Kampala, the United States and international agencies have implemented strict travel screening protocols, re-routing affected air passengers to designated global transit hubs.
A rapidly expanding outbreak of Ebola virus disease in East and Central Africa has officially escalated into the second-largest outbreak on record, according to an emergency briefing released by the United States Centers for Disease Control and Prevention (CDC).
Eko Hot Blog reports that health authorities confirmed that as of late June 2026, the Democratic Republic of the Congo (DRC) has registered more than 1,000 laboratory-confirmed cases.
EDITOR’S PICK
- Hamzat Appoints Obanikoro as Campaign DG Ahead of 2027 Lagos Governorship Race
- Tinubu’s State Police Plan Gains Momentum as Amendment Looms
- Residents Raise Alarm After Two Bodies Found in Lagos Waterway
The current crisis marks the 17th time the DRC has battled the viral hemorrhagic illness, but international epidemiologists are severely alarmed by the fact that the volume of infections has risen significantly faster during this specific wave than in any previously documented Ebola outbreak.
The crisis initially came to light in early May when a regional hospital located within the Bunia Health Zone in northeastern DRC detected a sudden cluster of severe illnesses heavily affecting frontline healthcare professionals.
While primary diagnostic samples initially yielded negative results for standard strains, advanced genetic sequencing later confirmed the presence of the Bundibugyo orthoebolavirus.
This specific variant is one of four distinct viral types capable of causing deadly hemorrhagic fever in human populations.
Public health officials face a critical hurdle as there is currently no licensed vaccine or specific antiviral therapy available to target the Bundibugyo strain, meaning patient management is restricted entirely to basic supportive hospital care.
The ongoing epidemic has completely outpaced all historical precedents for this specific strain.
The global medical community has only documented two prior outbreaks of the Bundibugyo virus, an initial wave in Uganda in 2007 and a subsequent occurrence in the DRC in 2012, which recorded devastating case-fatality rates of 32% and 55%, respectively.
The current multi-provincial spread has officially earned the grim title of the largest Bundibugyo-led emergency ever observed.
Patients caught in the current wave are presenting with classic, violent symptoms of Ebola disease, including sudden high fevers, debilitating physical weakness, severe abdominal pain, persistent vomiting, internal bleeding, and vomiting blood.
Geographically, the viral transmission has breached remote borders and penetrated dense urban environments. Within the DRC, the outbreak remains concentrated across the conflict-affected provinces of Ituri, Nord-Kivu, and Sud-Kivu.
However, cross-border movement has successfully carried the pathogen into neighboring Uganda, where confirmed cases have been officially tracked within the high-density capital city of Kampala.
This urban extension has prompted immediate global intervention, with the CDC issuing highest-tier Travel Health Notices for both nations, advising international travelers to strictly avoid non-essential transit to the eastern provinces of the DRC while requiring anyone exiting the region to rigorously monitor themselves for symptoms for at least 21 days.
To prevent international infiltration of the deadly pathogen, the CDC has partnered with international aviation agencies and the U.S. Department of Homeland Security to launch aggressive border control mechanisms.
All commercial air passengers departing or originating from the DRC, Uganda, and neighboring South Sudan, which is included purely as a proactive precaution due to vulnerable, porous borders, are subject to mandatory re-routing.
These travelers are being systematically channeled into major specialized screening gateways, including John F. Kennedy International Airport (JFK) in New York, Atlanta Hartsfield-Jackson International Airport (ATL), Washington-Dulles International Airport (IAD), and George Bush Intercontinental Airport (IAH) in Houston, where advanced public health containment teams remain on high alert.
